AVGR - Avinger receives 510(k) clearance for Tigereye ST image-guided CTO crossing system
2023-04-26 08:22:28 ET
- Avinger ( NASDAQ: AVGR ) has announced that the Co. has received 510(k) clearance from the U.S. FDA for Tigereye ® ST, its next-generation image-guided chronic total occlusion crossing system.
- Tigereye ST expands and advances Avinger's proprietary image-guided CTO product line with compelling new features and benefits.
- Avinger will initiate a limited launch of Tigereye ST in the current quarter with plans to expand to full commercial availability in the U.S. in the Q3 of 2023.
- "We are excited to initiate the limited launch of this new device and most of all to provide an important new tool for interventional physicians to treat their most challenging cases." said Jeff Soinski, Avinger's President and CEO.
- AVGR +38.34% premarket to $0.79.
For further details see:
Avinger receives 510(k) clearance for Tigereye ST image-guided CTO crossing system